An anti-hepatitis B drug with the lowest drug resistance rate
SINGENSU, a guanine nucleotide analog, inhibits the reverse transcriptase of hepatitis B virus. It is currently the anti-hepatitis B drug with the lowest drug resistance rate as well as favorable safety and tolerability,and also recommended as the first-line antiviral drug in many authoritative guidelines for the diagnosis and treatment of hepatitis B worldwide.
Indications
Chronic hepatitis B in adults with active viral replication, persistently elevated serum alanine aminotransferase (ALT), or active disease by liver histology.